Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine.
Katlama C, Pellegrin JL, Lacoste D, Aquilina C, Raffi F, Pialoux G, Vittecoq D, Raguin G, Lantz O, Mouroux M, Calvez V, Trylesinski A, Montestruc F, Dohin E, Goehrs JM, Delfraissy JF. Katlama C, et al. Among authors: dohin e. HIV Med. 2001 Jan;2(1):20-6. doi: 10.1046/j.1468-1293.2001.00046.x. HIV Med. 2001. PMID: 11737372 Free article. Clinical Trial.
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance.
Mouroux M, Yvon-Groussin A, Peytavin G, Delaugerre C, Legrand M, Bossi P, Do B, Trylesinski A, Diquet B, Dohin E, Delfraissy JF, Katlama C, Calvez V. Mouroux M, et al. Among authors: dohin e. J Clin Microbiol. 2000 Jul;38(7):2726-30. doi: 10.1128/JCM.38.7.2726-2730.2000. J Clin Microbiol. 2000. PMID: 10878071 Free PMC article. Clinical Trial.
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patients.
Michelet C, Ruffault A, Sébille V, Arvieux C, Jaccard P, Raffi F, Bazin C, Chapplain JM, Chauvin JP, Dohin E, Cartier F, Bellissant E. Michelet C, et al. Among authors: dohin e. Antimicrob Agents Chemother. 2001 Dec;45(12):3393-402. doi: 10.1128/AAC.45.12.3393-3402.2001. Antimicrob Agents Chemother. 2001. PMID: 11709314 Free PMC article. Clinical Trial.
Nelfinavir-induced urticaria and successful desensitization.
Demoly P, Messaad D, Trylesinski A, Faucherre V, Fabre J, Reynes J, Delmas C, Dohin E, Godard P, Bousquet J. Demoly P, et al. Among authors: dohin e. J Allergy Clin Immunol. 1998 Nov;102(5):875-6. doi: 10.1016/s0091-6749(98)70031-4. J Allergy Clin Immunol. 1998. PMID: 9819308 No abstract available.
Prevention of foscarnet nephrotoxicity.
Deray G, Katlama C, Dohin E. Deray G, et al. Among authors: dohin e. Ann Intern Med. 1990 Aug 15;113(4):332. doi: 10.7326/0003-4819-113-4-332_1. Ann Intern Med. 1990. PMID: 2165372 No abstract available.
Foscarnet nephrotoxicity: mechanism, incidence and prevention.
Deray G, Martinez F, Katlama C, Levaltier B, Beaufils H, Danis M, Rozenheim M, Baumelou A, Dohin E, Gentilini M, et al. Deray G, et al. Among authors: dohin e. Am J Nephrol. 1989;9(4):316-21. doi: 10.1159/000167987. Am J Nephrol. 1989. PMID: 2554731
34 results